Genetically Engineered Model Best Predicts Carboplatin Response
September 21, 2012
New cancer drugs must be thoroughly tested in preclinical models, often in mice, before they can be offered to cancer patients for the first time in phase I clinical trials. Key components of this process include pharmacokinetic and pharmacodynamic studies, … Read more